Binod Dhakal, MBBS¹, Othman S. Akhtar, MD^1*, Andrew J. Cowan, MD^2*, Shambavi Richard, MD³, Reed Friend^4*, Matthew J Rees, MD^5*, Patrick Costello, MS^6*, Mariola Vazquez Martinez^7*, Oren Pasvolsky, MD⁸, Charlotte B Wagner, PharmD^9*, Alexandria Jensen^10*, James A Davis, PharmD^11*, Ran Reshef, MD, MSc¹², Danai Dima^13*, Rahul Banerjee, MD, FACP¹⁴, Manisha Bhutani, MD¹⁵, Omar Nadeem, MD¹⁶, Ricardo D. Parrondo, MD¹⁷, Lekha Mikkilineni, MD, MA¹⁸, Shahzad Raza, MD¹⁹, Prashant Kapoor, MD²⁰, Hitomi Hosoya, MD, PhD¹⁸, Saurabh Chhabra, MD²¹, Ariel Grajales-Cruz^22*, Mahmoud R. Gaballa, MD²³, Shonali Midha, MD^24*, Melissa Alsina, MD^25*, Douglas W. Sborov, MD, MS²⁶, Krina K. Patel, MD, MSc²⁷, Yi Lin, MD, PhD²⁸, Christopher J Ferreri, MD^29*, Doris K. Hansen, MD³⁰, Luciano J. Costa, MD, PhD³¹ and Surbhi Sidana, MD³²

¹Division of Hematology and Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
²University of Washington, Seattle, WA
³Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY
⁴Levine Cancer Institute, Atrium Health Wake Forest University School of Medicine, Charlotte, NC
⁵Division of hematology, Mayo Clinic, Rochester
⁶Dana-Farber Cancer Institute, Boston, MA
⁷H. Lee Moffitt Cancer Center and Research Institute, Tampa
⁸MD Anderson Cancer Center, Houston
⁹Division of Hematology and Hematologic Malignancies, Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT
¹⁰Stanford University, Stanford
¹¹Division of Hematology-Oncology, Medical University of South Carolina, Charleston, SC
¹²Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY
¹³Cleveland Clinic, Cleveland
¹⁴University of Washington Fred Hutchinson Cancer Center, Seattle, WA
¹⁵Atrium Health Levin Cancer Institute, Charlotte, NC
¹⁶Center for Early Detection and Interception of Blood Cancers, Dana-Farber Cancer Institute, Boston, MA
¹⁷Division of Hematology-Oncology, Mayo Clinic-Florida, Jacksonville, FL
¹⁸Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Palo Alto, CA
¹⁹Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH
²⁰Mayo Clinic, Rochester, MN
²¹Division of Hematology, Mayo Clinic, Phoenix, AZ
²²Department of Blood and Marrow Transplantation and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa
²³The University of Texas MD Anderson Cancer Center, Houston, TX
²⁴Division of Hematologic Neoplasia, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
²⁵Moffitt Cancer Center, Tampa, FL
²⁶University of Utah School of Medicine, Salt Lake City, UT
²⁷M.D. Anderson Cancer Center, MD Anderson Cancer Center, Houston, TX
²⁸Division of Hematology, Mayo Clinic, Rochester, MN
²⁹Department of Hematologic Oncology and Blood Disorders, Atrium Health Levine Cancer Institute, Charlotte, NC
³⁰Department of Blood and Marrow Transplantation and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL
³¹Division of Hematology and Oncology, Department of Medicine, University of Alabama at Birmingham, Vestavia, AL
³²Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA

Andrew Kowalski, PharmD^1*, Jill Lykon, PharmD^2*, Benjamin Diamond, MD², David G. Coffey, MD², Marcella Kaddoura, MD³, Francesco Maura, MD⁴, James E. Hoffman², Dickran Kazandjian, MD² and Ola Landgren⁵

¹Myeloma Institute, Sylvester Comprehensive Cancer Center, University of Miami, Coral Gables, FL
²Myeloma Institute, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL
³Myeloma Institute, Sylvester Comprehensive Cancer Center, University of Miami, Dearborn, MI
⁴University of Miami, Coral Gables, FL
⁵Sylvester Comprehensive Cancer Center, Miami, FL

Aimaz Afrough^1*, Adeel M Khan, MD, MS, MPH², Eric Chinaeke^3*, Nina Kim^4*, Jinghua He^3*, Elissa E. Min^4,5*, Bingcao Wu^4*, Dee Lin^4*, Agne Paner-Straseviciute⁶, Laura Hester^7*, Jessica Fowler, PhD^4*, Sian Walker^8*, Christina Hearty^4* and Larry D Anderson Jr., MD, PhD²

¹Myeloma, Waldenstrom's, and Amyloidosis Program, Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX
²Myeloma, Waldenstrom’s, and Amyloidosis Program, Hematologic Malignancies and Cellular Therapy Program, Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX
³Janssen Scientific Affairs, LLC, Titusville, NJ
⁴Janssen Scientific Affairs, LLC, Horsham, PA
⁵Purdue University College of Pharmacy, West Lafayette, IN
⁶Janssen Scientific Affairs, Horsham, PA
⁷Janssen Research & Development, LLC, Horsham, PA
⁸Sierra Medical Affairs, LLC, Truckee, CA

Oren Pasvolsky, MD¹, Danai Dima, MD², Lei Feng, MS^3*, Wenli Dong^3*, Tiffany Richards, PhD, NP¹, James A Davis, PharmD^4*, Aimaz Afrough^5*, Mariola A Vazquez-Martinez, MD⁶, Aishwarya Sannareddy, MBBS^5*, Utkarsh Goel, MBBS⁷, Rahul Banerjee, MD, FACP⁸, Jack Khouri, MD⁹, Frances N. Cervoni Curet, MD^10*, Mahmoud R. Gaballa, MD¹, Alex Lieberman-Cribbin^11*, Masooma S Rana, MBBS^12*, Kelley Julian, PharmD^13*, Christopher J Ferreri, MD^14*, Leyla O. Shune, MD¹⁵, Shaun DeJarnette^15*, Evguenia Ouchveridze, MD¹⁶, Sandra Susanibar-Adaniya, MD¹⁷, Andrew J. Portuguese⁸, Hitomi Hosoya, MD, PhD¹⁸, Lekha Mikkilineni, MD, MA¹⁸, Gurbakhash Kaur, MD, MA¹⁹, Adriana Rossi, MD, MSc²⁰, Megan M Herr, PhD²¹, Daniel Schrum, PharmD^22*, Chenyu Lin, MD²², Shahzad Raza, MD², Yi Lin, MD, PhD²³, Shebli Atrash, MD²⁴, Joseph P. McGuirk, DO²⁵, Douglas W Sborov, MD²⁶, Peter M. Voorhees, MD²⁷, Faiz Anwer, MD², Melissa Alsina, MD²⁸, Ciara Louise Freeman, PhD, MSc, FRCPC, MRCP²⁹, Alfred L. Garfall, MD³⁰, Surbhi Sidana, MD³¹, Andrew J. Cowan, MD^32*, Larry D Anderson Jr., MD, PhD³³, Doris K. Hansen, MD^28*, Shambavi Richard, MD³⁴, Krina K. Patel, MD, MSc³⁵, Hans C. Lee, MD³⁶ and Ariel Grajales-Cruz^6*

¹The University of Texas MD Anderson Cancer Center, Houston, TX
²Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH
³Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX
⁴Division of Hematology-Oncology, Medical University of South Carolina, Charleston, SC
⁵UT Southwestern Simmons Cancer Center, Dallas, TX
⁶H Lee Moffitt Cancer Center and Research Institute, Tampa, FL
⁷Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, OH
⁸Fred Hutchinson Cancer Center, Seattle, WA
⁹Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
¹⁰Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
¹¹Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY
¹²Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University, Santa Clara, CA
¹³University of Utah Huntsman Cancer Institute, Salt Lake City, UT
¹⁴Department of Hematologic Oncology and Blood Disorders, Atrium Health Levine Cancer Institute, Charlotte, NC
¹⁵University of Kansas Medical Center, Kansas City, KS
¹⁶Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Westwood, KS
¹⁷Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
¹⁸Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Palo Alto, CA
¹⁹Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX
²⁰Mount Sinai, New York, NY
²¹Roswell Park Comprehensive Cancer Center, Buffalo, NY
²²Duke University Cancer Institute, Durham, NC
²³Division of Hematology, Mayo Clinic, Rochester, MN
²⁴Levine Cancer Institute, Charlotte, NC
²⁵Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Ctr., Westwood, KS
²⁶Huntsman Cancer Institute, University of Utah, Salt Lake City, UT
²⁷Plasma Cell Disorders Section, Department of Hematologic Oncology & Blood Disorders, Levine Cancer Center, Charlotte, NC
²⁸Moffitt Cancer Center, Tampa, FL
²⁹Department of Blood and Marrow Transplantation and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
³⁰University of Pennsylvania Abramson Cancer Center, Philadelphia, PA
³¹Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA
³²University of Washington Fred Hutchinson Cancer Center, Seattle, WA
³³Harold C. Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX
³⁴Icahn School of Medicine at Mount Sinai Tisch Cancer Institute, New York, NY
³⁵M.D. Anderson Cancer Center, MD Anderson Cancer Center, Houston, TX
³⁶Department of Lymphoma & Myeloma, MD Anderson Cancer Center, Houston, TX

Jordan Snyder, PharmD^1,2*, Dennis Grauer, MBA^3*, Nausheen Ahmed, MD^2,4, Al-Ola Abdallah, MD^2,5, Marc Hoffmann, MD⁵ and Zahra Mahmoudjafari, PharmD^2,5*

¹Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Overland Park, KS
²US Myeloma Innovations Research Collaborative (USMIRC), Kansas City, KS
³University of Kanas School of Pharmacy, Lawrence, KS
⁴University of Kansas Cancer Center, Kansas City, KS
⁵Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS

Doris K. Hansen, MD¹, Lauren C. Peres, PhD, MPH^2*, Danai Dima, MD³, Alicia Richards, PhD^4*, Leyla O. Shune, MD⁵, Aimaz Afrough, MD⁶, Shonali Midha, MD^7*, Binod Dhakal, MBBS⁸, Mehmet H. Kocoglu, MD⁹, Shebli Atrash, MD¹⁰, Chris Ferreri, MD¹⁰, Omar Castaneda, MD¹¹, James A Davis, PharmD^12*, Evguenia Ouchveridze, MD⁵, Joseph P. McGuirk, DO¹³, Charlotte B Wagner, PharmD^14*, Radhika Bansal, MBBS^15*, Patrick Costello, MS^16*, Kinaya Smith, MD^17*, Alex Lieberman-Cribbin^18*, Gabriel De Avila^19*, Sneha Purvey, MD²⁰, Hitomi Hosoya, MD, PhD²¹, Lekha Mikkilineni, MD, MA²², Laura B. Oswald, PhD^23*, Gurbakhash Kaur, MD, MA²⁴, Oren Pasvolsky, MD²⁵, Mahmoud R. Gaballa, MD²⁶, Megan M Herr, PhD²⁷, Peter A. Forsberg, MD²⁸, Murali Janakiram, MBBS²⁹, Myo Htut, MD²⁹, Sireesha Asoori, MBBS, MPH^30*, Nilesh Kalariya, PhD, RN^25*, Hamza Sloan Hashmi, MD^31*, Ran Reshef, MD, MSc³², Douglas W Sborov, MD³³, Omar Nadeem, MD³⁴, Faiz Anwer, MD³⁵, Jack Khouri, MD³⁶, Shahzad Raza, MD³⁷, Djordje Atanackovic, MD³⁸, Melissa Alsina, MD^39,40*, Ciara Louise Freeman, PhD, MSc, FRCPC, MRCP¹¹, Frederick L. Locke, MD⁴¹, Peter M. Voorhees, MD⁴², Larry D Anderson Jr., MD, PhD⁶, Shambavi Richard, MD¹⁸, Thomas Martin, MD³⁰, Yi Lin, MD, PhD⁴³, Krina K. Patel, MD, MSc⁴⁴ and Surbhi Sidana, MD⁴⁵

¹H. Lee Moffitt Cancer Center & Research Institute, Tampa
²Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, FL
³Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
⁴H. Lee Moffitt Cancer Center and Research Institute, Tampa
⁵University of Kansas Medical Center, Kansas City, KS
⁶Myeloma, Waldenstrom’s, and Amyloidosis Program, Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX
⁷Division of Hematologic Neoplasia, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
⁸Division of Hematology and Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
⁹University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore, MD
¹⁰Levine Cancer Institute, Charlotte, NC
¹¹Department of Blood and Marrow Transplantation and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
¹²Division of Hematology-Oncology, Medical University of South Carolina, Charleston, SC
¹³Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS
¹⁴Division of Hematology and Hematologic Malignancies, Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT
¹⁵Division of Hematology, Mayo Clinic, Bismarck, ND
¹⁶Dana-Farber Cancer Institute, Boston, MA
¹⁷Medical College of Wisconsin, Milwaukee, WI
¹⁸Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY
¹⁹H Lee Moffitt Cancer Center and Research Institute, Tampa, FL
²⁰Virginia Commonwealth University, Richmond, VA
²¹Division of Bone Marrow Transplant & Cellular Therapy,, Stanford University, Palo Alto, CA
²²Division of Blood and Marrow Transplant and Cellular Therapy, Stanford University, Palo Alto, CA
²³Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, FL
²⁴Division of Hematologic Malignancies and Cellular Therapy, Dept of Internal Medicine, Harold C. Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX
²⁵Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
²⁶The University of Texas MD Anderson Cancer Center, Houston, TX
²⁷Roswell Park Comprehensive Cancer Center, Buffalo, NY
²⁸University of Colorado, Aurora, CO
²⁹Judy and Bernard Briskin Center for Multiple Myeloma Research, City of Hope, Duarte, CA
³⁰UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA
³¹Myeloma Service, Division of Hematologic Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
³²Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY
³³Huntsman Cancer Institute, University of Utah, Salt Lake City, UT
³⁴Center for Early Detection and Interception of Blood Cancers, Dana-Farber Cancer Institute, Boston, MA
³⁵Cleveland Clinic Taussig Cancer Institute, Cleveland, OH
³⁶Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
³⁷Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Overland Park, KS
³⁸University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD
³⁹Moffitt Cancer Center, Tampa, FL
⁴⁰Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
⁴¹Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL
⁴²Plasma Cell Disorders Section, Department of Hematologic Oncology & Blood Disorders, Levine Cancer Center, Charlotte, NC
⁴³Division of Hematology, Mayo Clinic, Rochester, MN
⁴⁴M.D. Anderson Cancer Center, MD Anderson Cancer Center, Houston, TX
⁴⁵Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA